Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
MasTec
MTZ
$23B
| $16.5M | 0.04% |
536,400
+98,823
| +23% | +$3.72M |
|
|
OSG
577
Octave Specialty Group
OSG
$212M
| $16.5M | 0.04% |
603,900
+170,100
| +39% | +$4.93M |
|
|
HSNI
578
DELISTED
HSN, Inc.
HSNI
| $16.5M | 0.04% |
278,400
-34,200
| -11% | -$1.94M |
|
579
Sally Beauty Holdings
SBH
$1.55B
| $16.5M | 0.04% |
656,400
+433,374
| +194% | +$11.2M |
|
|
ARR
580
Armour Residential REIT
ARR
$2.37B
| $16.4M | 0.04% |
94,949
+45,165
| +91% | +$7.69M |
|
581
IDT Corp
IDT
$1.67B
| $16.4M | 0.04% |
1,335,549
+52,766
| +4% | +$613K |
|
582
Flex
FLEX
$45.9B
| $16.4M | 0.04% |
+1,968,145
| New | +$14.8M |
|
|
EGOV
583
DELISTED
NIC Inc
EGOV
| $16.3M | 0.04% |
1,030,360
+385,865
| +60% | +$6.73M |
|
584
T-Mobile US
TMUS
$197B
| $16.3M | 0.04% |
+483,650
| New | +$15.6M |
|
585
Park Aerospace
PKE
$811M
| $16.2M | 0.04% |
575,641
+19,341
| +3% | +$529K |
|
|
KND
586
DELISTED
Kindred Healthcare
KND
| $16.1M | 0.04% |
698,911
+187,100
| +37% | +$4.57M |
|
587
Repligen
RGEN
$9.45B
| $16.1M | 0.04% |
707,200
+241,207
| +52% | +$4.29M |
|
588
Green Plains
GPRE
$1.09B
| $16.1M | 0.04% |
489,343
-70,600
| -13% | -$2.08M |
|
|
BPL
589
DELISTED
Buckeye Partners, L.P.
BPL
| $16M | 0.04% |
192,434
-49,578
| -20% | -$3.87M |
|
|
TEN
590
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $15.9M | 0.04% |
242,400
-56,300
| -19% | -$3.49M |
|
591
Take-Two Interactive
TTWO
$45.2B
| $15.9M | 0.04% |
714,150
-123,967
| -15% | -$2.54M |
|
592
Steven Madden
SHOO
$3.46B
| $15.9M | 0.04% |
694,167
-50,736
| -7% | -$1.14M |
|
|
ARI
593
Apollo Commercial Real Estate
ARI
$886M
| $15.8M | 0.04% |
959,996
+370,500
| +63% | +$6.19M |
|
|
SBNY
594
DELISTED
Signature Bank
SBNY
| $15.8M | 0.04% |
124,874
+67,743
| +119% | +$8.15M |
|
|
DEG
595
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
| $15.7M | 0.04% |
933,600
+57,200
| +7% | +$1.01M |
|
|
FLG
596
Flagstar Bank National Association
FLG
$5.92B
| $15.7M | 0.04% |
326,742
+171,080
| +110% | +$8.03M |
|
597
Forward Air
FWRD
$682M
| $15.7M | 0.04% |
327,339
+24,500
| +8% | +$1.1M |
|
|
CNL
598
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $15.6M | 0.04% |
264,900
-16,000
| -6% | -$833K |
|
599
Hawaiian Electric Industries
HE
$2.04B
| $15.6M | 0.04% |
616,600
+277,859
| +82% | +$6.77M |
|
|
IL
600
DELISTED
IntraLinks Holdings Inc.
IL
| $15.6M | 0.04% |
1,755,700
+152,646
| +10% | +$1.37M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.